Literature DB >> 12595566

Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Mónica Campillos1, Miguel Angel García, Fernando Valdivieso, Jesús Vázquez.   

Abstract

Cell differentiation and development are highly regulated processes at the transcriptional level. One of the main transcription factors that regulate these processes is AP-2alpha, a cell-type specific protein required for vertebrate development and embryogenesis. AP-2alpha also regulates apoptosis and cell-cycle specific events by interacting with the oncogene c-Myc. In searching for novel AP-2alpha- interacting factors, using an affinity chromatography approach, we have observed that oncoprotein DEK interacts with AP-2alpha in vitro. The existence of an interaction between AP-2alpha and DEK in cellular cultures was demonstrated by expression of a tagged AP-2alpha form followed by immunodetection. By transient co-expression experiments using a reporter for APOE promoter activity we have found that DEK stimulates the transactivation activity of AP-2alpha over APOE promoter. Finally, electrophoretic mobility shift assays suggested that DEK enhances the DNA-binding activity of AP-2alpha. Our data suggest a novel cellular function of DEK as a transcriptional co-activator.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595566      PMCID: PMC149840          DOI: 10.1093/nar/gkg247

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  SAP - a putative DNA-binding motif involved in chromosomal organization.

Authors:  L Aravind; E V Koonin
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.

Authors:  V Alexiadis; T Waldmann; J Andersen; M Mann; R Knippers; C Gruss
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Identification of amino acid residues of transcription factor AP-2 involved in DNA binding.

Authors:  M A García; M Campillos; S Ogueta; F Valdivieso; J Vázquez
Journal:  J Mol Biol       Date:  2000-08-25       Impact factor: 5.469

4.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

5.  Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis.

Authors:  P J Mitchell; P M Timmons; J M Hébert; P W Rigby; R Tjian
Journal:  Genes Dev       Date:  1991-01       Impact factor: 11.361

6.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements.

Authors:  T Williams; A Admon; B Lüscher; R Tjian
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

7.  Characterization of the activation domains of AP-2 family transcription factors.

Authors:  S Wankhade; Y Yu; J Weinberg; M A Tainsky; P Kannan
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

8.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

Authors:  M von Lindern; M Fornerod; S van Baal; M Jaegle; T de Wit; A Buijs; G Grosveld
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  The MYC protein activates transcription of the alpha-prothymosin gene.

Authors:  M Eilers; S Schirm; J M Bishop
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  40 in total

1.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

Authors:  Ferdinand Kappes; Catalina Damoc; Rolf Knippers; Michael Przybylski; Lorenzo A Pinna; Claudia Gruss
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Functional domains of the ubiquitous chromatin protein DEK.

Authors:  Ferdinand Kappes; Ingo Scholten; Nicole Richter; Claudia Gruss; Tanja Waldmann
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  C/EBPα and DEK coordinately regulate myeloid differentiation.

Authors:  Rositsa I Koleva; Scott B Ficarro; Hanna S Radomska; Marlene J Carrasco-Alfonso; John A Alberta; James T Webber; C John Luckey; Guido Marcucci; Daniel G Tenen; Jarrod A Marto
Journal:  Blood       Date:  2012-04-03       Impact factor: 22.113

Review 5.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

6.  Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Authors:  Maroun Karam; Morgan Thenoz; Valérie Capraro; Jean-Philippe Robin; Christiane Pinatel; Agnès Lancon; Perrine Galia; David Sibon; Xavier Thomas; Sophie Ducastelle-Lepretre; Franck Nicolini; Mohamed El-Hamri; Youcef Chelghoun; Eric Wattel; Franck Mortreux
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 7.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

8.  Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.

Authors:  Stephen Mallon; Bassam T Wakim; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 9.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

10.  Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes.

Authors:  Francesca Orso; Davide Corà; Benedetta Ubezio; Paolo Provero; Michele Caselle; Daniela Taverna
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.